Two-component Signaling in candidiasis and aspergillosis

念珠菌病和曲霉病的双组分信号传导

基本信息

  • 批准号:
    6581738
  • 负责人:
  • 金额:
    $ 4.02万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2002
  • 资助国家:
    美国
  • 起止时间:
    2002-12-17 至 2005-11-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): This proposal is a request for funds from the Fogarty International Center to study the histidine kinases [HK] of Candida albicans and Aspergillus fumigatus The collaborative efforts of Dr R Calderone [Georgetown University] and Dr Ruoyu Li [Peking University First Hospital, Beijing, China] are to be utilized to understand the role of HK genes in the pathogenesis of candidiasis and aspergillosis. Dr Calderone is currently funded by the NIH-NIAID to characterize a specific HK from C albicans, while Dr. Li studies host immunity and the pathogenesis of aspergillosis Thus, the proposal combines the efforts of differently focused laboratories The project has four specific aims In aim 1, the temporal expression of HK genes from both organisms will be studied in animal models of each disease. Along with this objective, cytokine production in infected animals will be followed to assess the contribution of specific host responses to wild type and gene-deleted mutants Specific aim 2 will shift in emphasis to in vitro conditions, and the interaction ofA fumigatus and the corresponding gene-deleted strains with human neutrophils will be studied. In specific aim 3, clinical specimens from patients with oral or vaginal candidiasis infections as well as those with allergic or invasive aspergillosis will be screened by RT-PCR for HK gene transcription. In aim 4, the Calderone laboratory will complete the isolation of an A fumigatus HK gene originally found by the Li laboratory and construct gene-deleted strains for functional studies. In summary, the Li laboratory will provide expertise in the studies of immunity while the Calderone laboratory will assist the Li laboratory in molecular biology. Synergy will occur during this collaboration since the role of the HK in host responses will be defined while we will also further expand our understanding of the functions of HK genes from these organisms As expected, this collaboration will also provide new directions for the NIH parent grant of Dr Calderone
描述(由申请人提供):这项建议是向福格蒂国际中心申请资金,以研究白色念珠菌和烟曲霉的组氨酸激酶[HK]。将利用R Calderone博士[乔治敦大学]和李若瑜博士[北京大学第一医院,北京,中国]的合作努力,了解HK基因在念珠菌病和曲霉病发病机制中的作用。Calderone博士目前由NIH-NIAID资助,以确定来自白色念珠菌的特定HK的特征,而Li博士则研究宿主免疫和曲霉病的发病机制,因此,该建议结合了不同重点实验室的努力该项目有四个具体目标:目标1,将在每种疾病的动物模型中研究两种生物的HK基因的时间表达。根据这一目标,将在感染动物中产生细胞因子,以评估特定宿主对野生型和基因缺失突变体的贡献2将重点转移到体外条件下,并将研究烟曲霉菌和相应的基因缺失菌株与人中性粒细胞的相互作用。在具体目标3中,对口腔或阴道念珠菌病患者以及过敏性或侵袭性曲霉病患者的临床标本进行RT-PCR检测HK基因转录。在目标4中,Calderone实验室将完成Li实验室最初发现的A fumigatus HK基因的分离,并构建用于功能研究的基因缺失菌株。总而言之,LI实验室将提供免疫研究方面的专业知识,而Calderone实验室将协助LI实验室进行分子生物学研究。在这次合作中,由于HK在宿主反应中的作用将被明确,同时我们也将如预期的那样进一步扩大我们对这些生物的HK基因功能的理解,这一合作也将为NIH父母对卡尔德隆博士的资助提供新的方向

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Richard Arthur Calderone其他文献

Richard Arthur Calderone的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Richard Arthur Calderone', 18)}}的其他基金

Novel antifungal therapeutics
新型抗真菌疗法
  • 批准号:
    8327698
  • 财政年份:
    2011
  • 资助金额:
    $ 4.02万
  • 项目类别:
Novel antifungal therapeutics
新型抗真菌疗法
  • 批准号:
    8142570
  • 财政年份:
    2011
  • 资助金额:
    $ 4.02万
  • 项目类别:
DNA Repair Mechanisms in Candida albicans
白色念珠菌的 DNA 修复机制
  • 批准号:
    7002743
  • 财政年份:
    2003
  • 资助金额:
    $ 4.02万
  • 项目类别:
DNA Repair Mechanisms in Candida albicans
白色念珠菌的 DNA 修复机制
  • 批准号:
    6695813
  • 财政年份:
    2003
  • 资助金额:
    $ 4.02万
  • 项目类别:
DNA Repair Mechanisms in Candida albicans
白色念珠菌的 DNA 修复机制
  • 批准号:
    6833466
  • 财政年份:
    2003
  • 资助金额:
    $ 4.02万
  • 项目类别:
DNA Repair Mechanisms in Candida albicans
白色念珠菌的 DNA 修复机制
  • 批准号:
    6766002
  • 财政年份:
    2003
  • 资助金额:
    $ 4.02万
  • 项目类别:
Two-component Signaling in candidiasis and aspergillosis
念珠菌病和曲霉病的双组分信号传导
  • 批准号:
    6692618
  • 财政年份:
    2002
  • 资助金额:
    $ 4.02万
  • 项目类别:
Two-component Signaling in candidiasis and aspergillosis
念珠菌病和曲霉病的双组分信号传导
  • 批准号:
    6848773
  • 财政年份:
    2002
  • 资助金额:
    $ 4.02万
  • 项目类别:
TWO-COMPONENT SIGNAL PROTEINS OF ASPERGILLUS FUMIGATUS
烟曲霉的双组分信号蛋白
  • 批准号:
    6313418
  • 财政年份:
    2001
  • 资助金额:
    $ 4.02万
  • 项目类别:
TWO-COMPONENT SIGNAL PROTEINS OF ASPERGILLUS FUMIGATUS
烟曲霉的双组分信号蛋白
  • 批准号:
    6629371
  • 财政年份:
    2001
  • 资助金额:
    $ 4.02万
  • 项目类别:

相似海外基金

Development of a new treatment strategy for pulmonary aspergillosis by innate immune effector cells
先天免疫效应细胞开发肺曲霉病新治疗策略
  • 批准号:
    23K07941
  • 财政年份:
    2023
  • 资助金额:
    $ 4.02万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Development of an acute myeloid leukemia murine model of invasive pulmonary aspergillosis to gain insights into the role of leukemia and its treatments in the pathobiology of aspergillosis
开发侵袭性肺曲霉病的急性髓系白血病小鼠模型,以深入了解白血病及其治疗在曲霉病病理学中的作用
  • 批准号:
    10524878
  • 财政年份:
    2022
  • 资助金额:
    $ 4.02万
  • 项目类别:
The mechanism of secondary pulmonary aspergillosis after viral infection
病毒感染后继发肺曲霉菌病的机制
  • 批准号:
    22K08617
  • 财政年份:
    2022
  • 资助金额:
    $ 4.02万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Development of an acute myeloid leukemia murine model of invasive pulmonary aspergillosis to gain insights into the role of leukemia and its treatments in the pathobiology of aspergillosis
开发侵袭性肺曲霉病的急性髓系白血病小鼠模型,以深入了解白血病及其治疗在曲霉病病理学中的作用
  • 批准号:
    10622540
  • 财政年份:
    2022
  • 资助金额:
    $ 4.02万
  • 项目类别:
Regulation of Inflammatory Pathology in Invasive Aspergillosis
侵袭性曲霉病炎症病理学的调节
  • 批准号:
    10427455
  • 财政年份:
    2021
  • 资助金额:
    $ 4.02万
  • 项目类别:
Influenza Attenuates Innate Pulmonary Host Defense against Invasive Pulmonary Aspergillosis
流感削弱肺宿主对侵袭性肺曲霉病的先天防御
  • 批准号:
    10835161
  • 财政年份:
    2021
  • 资助金额:
    $ 4.02万
  • 项目类别:
Influenza Attenuates Innate Pulmonary Host Defense against Invasive Pulmonary Aspergillosis
流感削弱肺宿主对侵袭性肺曲霉病的先天防御
  • 批准号:
    10449394
  • 财政年份:
    2021
  • 资助金额:
    $ 4.02万
  • 项目类别:
Regulation of Inflammatory Pathology in Invasive Aspergillosis
侵袭性曲霉病炎症病理学的调节
  • 批准号:
    10286538
  • 财政年份:
    2021
  • 资助金额:
    $ 4.02万
  • 项目类别:
Influenza Attenuates Innate Pulmonary Host Defense against Invasive Pulmonary Aspergillosis
流感削弱肺宿主对侵袭性肺曲霉病的先天防御
  • 批准号:
    10651832
  • 财政年份:
    2021
  • 资助金额:
    $ 4.02万
  • 项目类别:
Is the excess mortality amongst tuberculosis survivors explained by Chronic Pulmonary Aspergillosis? Investigating burden, diagnosis, and therapy
结核病幸存者死亡率过高是否可以用慢性肺曲霉病来解释?
  • 批准号:
    nhmrc : 1196100
  • 财政年份:
    2021
  • 资助金额:
    $ 4.02万
  • 项目类别:
    Investigator Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了